全文获取类型
收费全文 | 6172篇 |
免费 | 608篇 |
国内免费 | 301篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 44篇 |
妇产科学 | 40篇 |
基础医学 | 1618篇 |
口腔科学 | 102篇 |
临床医学 | 400篇 |
内科学 | 1227篇 |
皮肤病学 | 91篇 |
神经病学 | 439篇 |
特种医学 | 138篇 |
外国民族医学 | 2篇 |
外科学 | 259篇 |
综合类 | 783篇 |
现状与发展 | 1篇 |
预防医学 | 194篇 |
眼科学 | 238篇 |
药学 | 678篇 |
2篇 | |
中国医学 | 93篇 |
肿瘤学 | 699篇 |
出版年
2024年 | 9篇 |
2023年 | 108篇 |
2022年 | 149篇 |
2021年 | 255篇 |
2020年 | 196篇 |
2019年 | 206篇 |
2018年 | 214篇 |
2017年 | 203篇 |
2016年 | 198篇 |
2015年 | 271篇 |
2014年 | 406篇 |
2013年 | 415篇 |
2012年 | 406篇 |
2011年 | 473篇 |
2010年 | 378篇 |
2009年 | 382篇 |
2008年 | 398篇 |
2007年 | 378篇 |
2006年 | 362篇 |
2005年 | 311篇 |
2004年 | 273篇 |
2003年 | 230篇 |
2002年 | 149篇 |
2001年 | 120篇 |
2000年 | 102篇 |
1999年 | 67篇 |
1998年 | 65篇 |
1997年 | 63篇 |
1996年 | 50篇 |
1995年 | 43篇 |
1994年 | 35篇 |
1993年 | 29篇 |
1992年 | 27篇 |
1991年 | 21篇 |
1990年 | 23篇 |
1989年 | 7篇 |
1988年 | 15篇 |
1987年 | 7篇 |
1986年 | 2篇 |
1985年 | 8篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1980年 | 3篇 |
1979年 | 2篇 |
1977年 | 1篇 |
排序方式: 共有7081条查询结果,搜索用时 156 毫秒
91.
立足于库车前陆盆地南缘油气勘探,以库车南缘古隆起研究为切入点,通过区域地震大剖面建立构造格架,开展了库车南缘古生界—中生界全层位精细解释,刻画出中生界及古隆起的分布,分析了古隆起的沉积、构造响应特征,以及古隆起对库车油气运聚的控制作用。总结出库车前陆盆地油气分布规律具有两个特点:主力油气聚集在隆起北缘,沿着断层以垂向短距离运移为主,油气分布层位集中,东西向具有明显分段性;油气沿着主要输导层横向长距离运移,古隆起上部及南缘也聚集大量油气,油气分布层位多,东西向差异大。指出库车南缘4个油气勘探领域与主要勘探类型。 相似文献
92.
93.
To date, most studies of Shc family of signaling adaptor proteins have been focused on the near-ubiquitously expressed ShcA, indicating its relevance to age-related diseases and longevity. Although the role of the neuronal ShcC protein is much less investigated, accumulated evidence suggests its importance for neuroprotection against such aging-associated conditions as brain ischemia and oxidative stress. Here, we summarize more than decade of studies on the ShcC expression and function in normal brain, age-related brain pathologies and immune disorders with a focus on the interactions of ShcC with signaling proteins/pathways, and the possible implications of these interactions for changes associated with aging. 相似文献
94.
95.
Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies 总被引:7,自引:0,他引:7
Helicobacter pylori infects the stomach of half of the human population worldwide and causes chronic active gastritis, which can lead to peptic ulcer disease, gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. The host immune response to the infection is ineffective, because the bacterium persists and the inflammation continues for decades. Bacterial activation of epithelial cells, dendritic cells, monocytes, macrophages, and neutrophils leads to a T helper cell 1 type of adaptive response, but this remains inadequate. The host inflammatory response has a key functional role in disrupting acid homeostasis, which impacts directly on the colonization patterns of H pylori and thus the extent of gastritis. Many potential mechanisms for the failure of the host response have been postulated, and these include apoptosis of epithelial cells and macrophages, inadequate effector functions of macrophages and dendritic cells, VacA inhibition of T-cell function, and suppressive effects of regulatory T cells. Because of the extent of the disease burden, many strategies for prophylactic or therapeutic vaccines have been investigated. The goal of enhancing the host's ability to generate protective immunity has met with some success in animal models, but the efficacy of potential vaccines in humans remains to be demonstrated. Aspects of H pylori immunopathogenesis are reviewed and perspectives on the failure of the host immune response are discussed. Understanding the mechanisms of immune evasion could lead to new opportunities for enhancing eradication and prevention of infection and associated disease. 相似文献
96.
97.
98.
99.
Wen Cheng Xiufang Ren Jinquan Cai Chuanbao Zhang Mingyang Li Kuanyu Wang Yang Liu Sheng Han Anhua Wu 《Oncotarget》2015,6(30):29285-29295
Although O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation status is an important marker for glioblastoma multiforme (GBM), there is considerable variability in the clinical outcome of patients with similar methylation profiles. The present study aimed to refine the prognostic and predictive value of MGMT promoter status in GBM by identifying a micro (mi)RNA risk signature. Data from The Cancer Genome Atlas was used for this study, with MGMT promoter-methylated samples randomly divided into training and internal validation sets. Data from The Chinese Glioma Genome Atlas was used for independent validation. A five miRNA-based risk signature was established for MGMT promoter-methylated GBM to distinguish cases as high- or low-risk with distinct prognoses, which was confirmed using internal and external validation sets. Importantly, the prognostic value of the signature was significant in different cohorts stratified by clinicopathologic factors and alkylating chemotherapy, and a multivariate Cox analysis found it to be an independent prognostic marker along with age and chemotherapy. Based on these three factors, we developed a quantitative model with greater accuracy for predicting the 1-year survival of patients with MGMT promoter-methylated GBM. These results indicate that the five-miRNA signature is an independent risk predictor for GBM with MGMT promoter methylation and can be used to identify patients at high risk of unfavorable outcome and resistant to alkylating chemotherapy, underscoring its potential for personalized GBM management. 相似文献
100.
Rosa Murria Sarai Palanca Inmaculada de Juan Cecilia Egoavil Cristina Alenda Zaida García-Casado María J Juan Ana B Sánchez Ana Santaballa Isabel Chirivella ángel Segura David Hervás Marta Llop Eva Barragán Pascual Bolufer 《American journal of cancer research》2015,5(1):375-385
This study investigates the relationship of promoter methylation in tumor suppressor genes with copy-number aberrations (CNA) and with tumor markers in breast cancer (BCs). The study includes 98 formalin fixed paraffin-embedded BCs in which promoter methylation of 24 tumour suppressor genes were assessed by Methylation-Specific Multiplex Ligation-dependent Probe Amplification (MS-MLPA), CNA of 20 BC related genes by MLPA and ER, PR, HER2, CK5/6, CK18, EGFR, Cadherin-E, P53, Ki-67 and PARP expression by immunohistochemistry (IHC). Cluster analysis classed BCs in two groups according to promoter methylation percentage: the highly-methylated group (16 BCs), containing mostly hyper-methylated genes, and the sparsely-methylated group (82 BCs) with hypo-methylated genes. ATM, CDKN2A, VHL, CHFR and CDKN2B showed the greatest differences in the mean methylation percentage between these groups. We found no relationship of the IHC parameters or pathological features with methylation status, except for Catherin-E (p = 0.008). However the highly methylated BCs showed higher CNA proportion than the sparsely methylated BCs (p < 0.001, OR = 1.62; IC 95% [1.26, 2.07]). CDC6, MAPT, MED1, PRMD14 and AURKA showed the major differences in the CNA percentage between the two groups, exceeding the 22%. Methylation in RASSF1, CASP8, DAPK1 and GSTP1 conferred the highest probability of harboring CNA. Our results show a new link between promoter methylation and CNA giving support to the importance of methylation events to establish new BCs subtypes. Our findings may be also of relevance in personalized therapy assessment, which could benefit the hyper methylated BC patients group. 相似文献